Pharmaceutical IP and competition law in South Africa: overview

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to pharmaceutical IP and competition law in South Africa.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

To read the full Q&A, visit Thomson Reuters Practical Law.

For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.

View Related Blogs
View All
news

Out with the Old and in with the New: Refreshing your brand with Intellectual Property in Mind

What do the following brands all have in common? A brand refresh, of course! Refreshing your brand can be an exciting way to modernise your business and keep it relevant to customers. But while you...

Intellectual PropertyMelissa MorrisTrade Marks
news

Mr D’s disparaging advertisement that imitated Massmart’s MAKRO MOOD Campaign

The Directorate of the Advertising Regulatory Board (“ARB”) was recently called upon to adjudicate a competitor complaint filed by Massmart IP (Pty) Ltd against Mr Delivery (Pty) Ltd. Mr D’s adv...

Debbie MarriottIntellectual PropertyRebone SetatiTrade Marks